01453nas a2200181   4500000000100000008004100001100001400042700001300056700001800069700001200087700001600099700001300115245008400128300001100212490000700223520102700230022001401257       2015                            d1 aMüller K1 aKarrer S1 aApfelbacher C1 aBlome C1 aBerneburg M1 aKoller M00a[Quality of life in dermatology: From measurement to practical implementation].  a287-980 v663 a<p>Health-related quality of life has not only been established as an important patient-reported outcome measure in patient care but has been defined as an evaluation criterion for therapies in the German Code of Social Law as well as in the guidelines of the American Food and Drug Administration and of the European Medicines Agency (EMA). Quality of life can be measured in a standardised manner. Validated questionnaires are available for recording specific problems of patients with, for example, skin diseases. Measuring quality of life has not yet been implemented into daily dermatological routine, although (1) studies have confirmed that the measurement of quality of life offers major benefits for the treatment of skin diseases, and (2) first experiences in implementing quality of life measurement into practice have been positive. The further implementation of systemically measuring quality of life requires advancements in automated measurement and the assumption of cost by social health insurances.</p>
  a1432-1173